Heparan sulphate glycosaminoglycans in the glomerular filtration barrier

Completed

• Conditions: 10083624; Multiple osteochondromas

• Registration Number: NL-OMON42338
• Lead Sponsor: eids Universitair Medisch Centrum

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Last Update Posted: 23 April 2024

Recruitment & Eligibility

• Status: Completed
• Sex: Not specified
• Target Recruitment: 80

Inclusion Criteria

Subjects should be over 18 years of age and capacitated.

Exclusion Criteria

No confirmed mutation status in either the EXT1 or EXT2 gene

Study & Design

• Study Type: Observational non invasive
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
<p>The main study parameters are the differences in proportion of subjects with<br /><br>micro-albuminuria, urinary albumin/creatinine ratio, and the difference in<br /><br>perfused boundary region between patients and controls. </p><br>

Secondary Outcome Measures

Name	Time	Method
<p>N/A</p><br>